Heart Disease News and Research

Latest Heart Disease News and Research

Some hospitals face financial upheaval under new NHS payment system

Some hospitals will face sizeable changes to their incomes under a new NHS payment system, say researchers at Dr Foster in this week's BMJ.

18 Nov 2004

New findings have implications for chronic use of COX-2 Inhibitors in pre-menopausal women

Heart disease is less pronounced in women than in men as humans age, but this difference narrows after menopause. Some studies have shown that estrogen slows heart disease in mouse models, but the mechanism is largely unknown.

18 Nov 2004

Eating apples may protect against Alzheimer's and Parkinsonism

A group of chemicals in apples could protect the brain from the type of damage that triggers such neurodegenerative diseases as Alzheimer's and Parkinsonism, according to two new studies from Cornell University food scientists.

18 Nov 2004

FDA clarifies it's position on Vioxx

For the past several weeks, various allegations and characterizations have circulated and been reported on regarding FDA's approval and post market review of the drug Vioxx, a "Cox-2 inhibitor," that its sponsor, Merck, voluntarily withdrew from the market September 30th, 2004.

17 Nov 2004

Sit down rounds improve outcomes for kidney dialysis patients

"Sit-down" medical rounds, during which a health care team meets to review a patient's medical record and discuss short- and long-term needs, are associated with better outcomes for kidney dialysis patients, a Johns Hopkins-directed study has found.

17 Nov 2004

Ground-level ozone significantly associated with an increase in deaths in many U.S. cities

Changes in ground-level ozone were significantly associated with an increase in deaths in many U.S. cities, according to a nationwide study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health and the Yale University School of Forestry and Environmental Studies.

17 Nov 2004

Concord grapes increase good cholesterol

Drinking Concord grape juice significantly increased HDL--the good cholesterol--and significantly lowered two markers of inflammation in people with stable coronary artery disease, according to results of a study presented in the November issue of the journal Arteriosclerosis, Thrombosis and Vascular Biology.

16 Nov 2004

White Paper aims to reduce the number of people who smoke

Health Secretary John Reid today published Choosing Health – the Government’s White Paper on improving public health in England.

16 Nov 2004

Startling new blood pressure findings - atherosclerosis slowed

A new study led by The Cleveland Clinic shows that giving blood pressure lowering medication to heart disease patients with a “normal” blood pressure dramatically reduces risk of adverse cardiac events and slows disease progression.

16 Nov 2004

Troponin genes offer new insights to familial heart failure

Mutations in the troponin protein complex may be useful for predicting the course of heart failure due to dilated cardiomyopathy and also for guiding treatment and research, according to a new study in the Nov. 16, 2004 issue of the Journal of the American College of Cardiology.

16 Nov 2004

Vasogen announces full patient enrollment in its trial of Celacade in peripheral arterial disease

Vasogen today announced that it has reached full enrollment in its 500-patient pivotal phase III SIMPADICO trial of Celacade (immune modulation therapy) for the treatment of peripheral arterial disease (PAD).

16 Nov 2004

Keeping fit lowers C-Reactive protein in people with metabolic syndrome

In people with signs of metabolic syndrome, including high blood pressure, high triglycerides, high cholesterol, elevated blood glucose and obesity, physical activity appears to reduce a marker for inflammation which has been linked to heart disease

16 Nov 2004

Acetaminophen shows positive cardioprotective effects In heart attack, arrhythmia

Long an under-studied yet widely-used over-the-counter medication, acetaminophen over the last few years is becoming recognized for a range of potential therapeutic uses beyond headache and pain.

16 Nov 2004

Research shows that even bacteria don't put their eggs in one basket

Diversification helps reduce overall risk by putting your eggs in more than one basket and is a strategy that strengthens groups of all kinds -- from forests challenged with environmental stress to stock market portfolios in uncertain times. Findings from University of Iowa researchers show that even bacteria have learned this important lesson.

16 Nov 2004

Cotinine not linked to hearing loss

Levels of cotinine, a chemical that is made by the body from nicotine, which is found in cigarette smoke, does not appear to be linked to hearing loss, according to an article in the November issue of The Archives of Otolaryngology – Head & Neck Surgery.

16 Nov 2004

Computer vignette effective at measuring quality of physician practice

A new measurement tool called the computerized clinical vignette can help clinicians and policymakers assess and improve the quality of physician practice while potentially reducing costs, according to a study led by a researcher at the San Francisco VA Medical Center (SFVAMC).

16 Nov 2004

Fluorescent protein tool may speed identification of molecular changes that reveal cells' inner workings

Scientists at Johns Hopkins and the University of Texas Medical Branch have created a new tool that easily reveals when and where a key cellular signal is active.

16 Nov 2004

Low carb diets, like the Atkins and South Beach Diets, may be the best option for men who want to slim

New research, published in the BioMedCentral journal, Nutrition & Metabolism, shows that over 70% of men lost more weight and fat on a low carbohydrate diet, despite eating more calories.

14 Nov 2004

Vaccine provides new hope to the millions of people who suffer from food allergies

A team led by a researcher at the Stanford University School of Medicine has developed vaccines that vastly reduce or eliminate dogs' allergic reactions to three major food allergens: peanuts, milk and wheat. The vaccines' benefits lasted at least three months.

14 Nov 2004

Use of the drug etodolac instead of drugs like Celebrex or Bextra could save $40 million annually

People in search of pain relief who take the generic anti-inflammatory etodolac suffer 60 percent fewer gastrointestinal complications than those who take similar drugs, according to researchers at UT Southwestern Medical Center at Dallas and the Dallas Veterans Affairs Medical Center.

14 Nov 2004

Heart Disease News and Research

Latest Heart Disease News and Research

Some hospitals face financial upheaval under new NHS payment system

New findings have implications for chronic use of COX-2 Inhibitors in pre-menopausal women

Eating apples may protect against Alzheimer's and Parkinsonism

FDA clarifies it's position on Vioxx

Sit down rounds improve outcomes for kidney dialysis patients

Ground-level ozone significantly associated with an increase in deaths in many U.S. cities

Concord grapes increase good cholesterol

White Paper aims to reduce the number of people who smoke

Startling new blood pressure findings - atherosclerosis slowed

Troponin genes offer new insights to familial heart failure

Vasogen announces full patient enrollment in its trial of Celacade in peripheral arterial disease

Keeping fit lowers C-Reactive protein in people with metabolic syndrome

Acetaminophen shows positive cardioprotective effects In heart attack, arrhythmia

Research shows that even bacteria don't put their eggs in one basket

Cotinine not linked to hearing loss

Computer vignette effective at measuring quality of physician practice

Fluorescent protein tool may speed identification of molecular changes that reveal cells' inner workings

Low carb diets, like the Atkins and South Beach Diets, may be the best option for men who want to slim

Vaccine provides new hope to the millions of people who suffer from food allergies

Use of the drug etodolac instead of drugs like Celebrex or Bextra could save $40 million annually

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Heart Disease News and Research

Latest Heart Disease News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in